ENTECAVIR
NDC 42494-458, ENTECAVIR ANHYDROUS, tablet, from Cameron Pharmaceuticals.
- Product NDC
- 42494-458
- Status
- Listed
- Labeler
- Cameron Pharmaceuticals
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216857
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42494-458 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ENTECAVIR ANHYDROUS1 mg/1
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Analog [EXT]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42494-458-30 | 42494045830 | 30 TABLET in 1 BOTTLE (42494-458-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/92a5bebd-6408-463d-933c-bab8338a677eNADAC price for package 42494045830
GET /v1/drugs/nadac/42494045830
Use it
Look up 42494-458 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42494-458 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42494-458. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.